According to experts in the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine, there were approximately 3,300 deaths and 400,000 injuries nationwide in 2011 due to collisions involving distracted driving. With April being national distracted driving awareness month, a team of researchers released survey results that reveal the habits of San Diego County drivers who use their cell phone while behind the wheel.
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
The President of the United States gathered together on April 2, “some of the smartest people in the country, some of the most imaginative and effective researchers in the country,” he said, to hear him announce a broad and collaborative research initiative designed to revolutionize our understanding of the brain.
Initial studies at the University of California, San Diego School of Medicine indicate that a self-help treatment program for overweight children and their parents, guided by clinical experts, may be an effective solution. The study, led by Kerri Boutelle, PhD, associate professor of pediatrics and psychiatry at UC San Diego School of Medicine – the first to demonstrate the effectiveness of such a program – will be published in the journal Pediatrics on April 1.
On Saturday, April 13 from 8 a.m. to 3:00 p.m., UC San Diego Health System is hosting an interactive conference in La Jolla, focused on women’s health. The event is free and open to the public. Fifteen leading experts will host insightful talks on subjects, including stress reduction, gene therapy for heart repair, cancer prevention, successfully reducing menopause symptoms, and achieving longevity through diet and fitness.
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, says a key protein in Schwann cells performs a critical, perhaps overarching, role in regulating the recovery of peripheral nerves after injury. The discovery has implications for improving the treatment of neuropathic pain, a complex and largely mysterious form of chronic pain that afflicts over 100 million Americans.
